聚合搜Scholar - 壹搜网为您找到"
AI智能体取代20%人机互动
"相关结果 10条Approximately 5%-10% of the general population respond inadequately to licensed recombinant hepatitis B vaccines. We assessed the immunogenicity and safety of a new HBAI20 vaccine, consisting of a new AI20 adjuvant (20-µg recombinant human IL-2 attached to 20-µg aluminium hydroxide) in combination with HBVaxPro®-10 µg.
www.ncbi.nlm.nih.gov